LPTI Longport Inc (CE)

Longport, Inc. (OTC PK: LPTI), a medical technology specialist in high-frequency, high-resolution ultrasound imaging, today announced that two papers have recently been published in peer-reviewed journals that report on the utilization of Longport�s EPISCAN system. The first paper, published in the November/December 2006 issue of Advances in Skin & Wound Care, presents the use of Longport�s EPISCAN for imaging the pathology of early-stage pressure ulcers and the utility of high-resolution ultrasound in the early detection of this condition. This paper concludes, �A better understanding of the pathogenesis of pressure ulcers through the use of high-resolution ultrasound to detect soft tissue damage and edema before visible clinical signs could lead to earlier and more focused pressure ulcer prevention programs, resulting in reduced pain and suffering for improved patient quality of life and wound care cost savings.� The full reference to this paper is: Use of High-Resolution, High-Frequency Diagnostic Ultrasound to Investigate the Pathogenesis of Pressure Ulcer Development. Advances in Skin & Wound Care. 19(9):498-505, November/December 2006. The second paper, published in the Tissue Viability Supplement of the British Journal of Nursing, reports on a case study using high-resolution ultrasound to assess chronic wounds. One of the key points of this paper is, �High-frequency ultrasound could be used to image and quantify changes in the wounds as a means of non-invasively visualizing wound characteristics which would otherwise be missed using standard visual assessments alone.� The full reference to this paper is: Has Packing Sinus Wounds Become a Ritualistic Practice? British Journal of Nursing - Volume 15, Number 19: 26 October-8 November 2006. Tissue Viability Supplement, pages S27-30. Further details on both papers can be viewed at the News section of Longport�s website: http://www.longportinc.com/about/news.html. �These studies contribute to the validation of our technology essential for the documentation of positive clinical outcomes, clinical acceptance and clinical use,� said Connie Phillips-Jones, RN, MSN Longport�s Director of Clinical Support. About Longport, Inc. Longport, Inc. of Glen Mills, Pennsylvania, is a medical technology company that specializes in high-resolution ultrasound imaging. After several years and a multimillion dollar investment in the technology, Longport has secured patents, copyrights and FDA permission to market. The Company�s technology has been used to engineer a unique high-resolution ultrasound imaging system. For further information please contact Longport, Inc. at 1-800-289-6863 or visit our website at www.longportinc.com. Forward-looking Information and the Private Securities Litigation Reform Act of 1995 Certain statements in this press release, including statements concerning product development milestones and anticipated events, are �forward-looking statements� within the Private Litigation Reform Act of 1995. Forward-Looking Statements are based on the opinions and estimates of management at the time the statements are made and are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements. The words �believe,� �expect,� �intend,� �anticipate,� variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could affect Longport�s actual results include, among others, uncertainties as to the Company�s ability to manage potential problems, delays or anticipated expenses, including problems, delays or expenses involving manufacturing. Readers are cautioned not to place undue reliance upon these forward-looking statements that speak only to the date of this release. Reference is made to Longport�s 2004 annual report on Form 10-K filed with the Securities and Exchange Commission for a more definitive description of such factors. Longport, Inc. undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.